proven
issue
supplied
taken
implementation
sole
concludes
vv
london
potentially
resentatives
medicine
manufac
twenty
excluded
trust
contribute
exercise
nies
wait
contributions
pawn
ciccio
establishes
globalization
address
considers
chip
project
industrial
2002
option
magazine
proof
commodities
healthnutritionandpopulatiore
dependence
appropriate
medi
importance
people
identify
recognised
treated
conditions
source
protection
processes
failed
brazil
really
dures
allowing
therapeutically
tual
provi
alegre
chaves
disclosed
reducing
issuing
sufficient
lack
hille
even
wt
1975
ltd
keppel
immediately
acceptance
challenges
ance
return
serious
flexibilities
undisclosed
keep
better
yours
obstacle
1980s
supply
final
news03_e
foster
already
velasquez
subsequent
htm
inform
lenges
exchange
grounds
heavily
triumph
drugs
latter
doc
fold
position
holding
owner
020105_hgap_fs_india_ipr
continues
estimating
financing
table
minimally
news_e
tus
trading
partner
delay
substantial
burden
references
set
country
igate
unrecognised
tial
remedies
strengthening
leader
outline
could
replicate
cfm
marily
allocate
sanofi
coordination
research
trepidation
sion
parties
facilitate
unctad
application
protected
laws
ictsd
provider
procedures
both
disseminating
fostering
ments
licensee
offered
decisions
rev
prior
ciprofloxacin
morocco
programs
located
inequality
creation
inade
would
b3995001
bennett
european
181
412
doing
spurred
stimulating
adopted
global
adapt
third
governments
ifications
erty
govern
kenya
disease
bargaining
chased
behind
proponents
afford
ern
approach
efficacy
produc
elsewhere
threat
enter
foreign
aus
kaletra
rather
unfair
advisory
closely
sions
reduces
volume
difficulties
ustr
higher
tests
concerted
deci
results
globally
jordan
key
minimise
experiences
ond
pared
hope
importation
wg4
cially
right
chile
protecting
tb
funding
extent
burdensome
brazil's
measures
four
zation
sentative
introduce
novartis
recommendations
orig
affected
individual
legislative
subsumed
entire
who
purchased
affirm
670
bellagio
149
emerging
dimasi
fta
foremost
exclude
sharing
failure
institutions
bean
leading
pre
20innovation
studies
legisla
fustukian
action
many
sighted
disputed
prac
considerably
author
jm
affairs
act
initiated
enabling
provide
pharmaceu
supporting
omy
way
lacking
exporting
4000
safeguards
preview
ensp
implications
pandemic
remaining
representative
squibb
integrating
investment
generics
focused
fast
ftas
succeed
patient
concerning
nology
guatemala
cid
southern
msf
gmail
series
arvs
ests
adopting
purchase
resource
alone
jour
little
setbacks
pressures
correctly
compliant
relation
away
creating
uncertainty
beyond
ecosoc
rules
qualities
intel
engage
original
increase
mip
sec
fortune
suggested
canada
doi
withhold
2001
aids
published
tive
override
possible
months
kept
tabled
dhhs10242001
members
length
internationalisation
what_we_do
law
collective
understand
turn
past
export
cost
jack
biological
passed
myeloid
introduced
asserting
agricultural
engaged
venting
improper
story3
tomossy
lic
under
australia_fta
hygiene
nego
move
our
its
onus
overly
asset_upload_file273_3234
union
promoting
eu
ine
leverhulme
1harvard
accepted
merce
dan
medical
soon
incurring
permit
kong
ftaa
end
clarifications
alcorn
reach
sultation
failures
workable
particular
classified
cumbersome
implement
than
without
costing
digest
effective
department
monopoly
intransigent
technolog
reviews
supplies
reduction
borders
tional
technology
fears
conceded
effort
rapid
ranson
2000
affirmed
articleid
deadline
image
manufacture
onstrate
consent
thesis
chair
practice
order
bargained
following
bio
restrictions
data
ignored
dfid
opposed
versions
after
2005_special_301
tran
permitted
irrational
india
pr350_e
cm_data
dor
stumbled
growing
shadows
adapting
inequalities
gf
final_report
1997
salva
came
revoked
reluctant
ohrlls
protect
takes
stands
unpatented
document_library
collectively
assessment
strongly
identifi
capac
php
nigeria
whole
went
medications
new
centre
org
promote
vital
reviewed
send
limitations
recognising
states
needed
develop
exam
pal
holders
briefing
affordable
zil's
negotiation
enhance
conclusion
cited
your
describes
consequences
actual
calls
quate
donor
fields
japan
vulnerable
profile
holder
begins
discussions
actually
special
essary
criteria
adaptive
describe
reflects
reli
plavix
brantner
money
chains
collaboratively
reject
eight
interpret
forward
pepfar
technological
expedited
acquired
indinavir
compared
nuffield
barriers
protec
freely
cution
cebeb882
did
ten
sought
investing
announced
any
inal
synchronizing
doha
ted
more
island
groups
regarding
report
authorities
be
september
covery
detailed
most
cationj
had
information
802
problematic
ldc
leadership
chronic
phar
pipeline
extends
validity
asia
again
of
much
procedure
neither
part
540
lopinavir
tively
settle
fact
lifetime
seen
stocrin
drug
upon
only
frontieres
homedesgenericdrugfi
proposals
proceedings
means
aggregate
requirements
11da
benefited
1000
clarifies
biomed
reasonable
ibilities
producing
devel
publishing_adv
strong
voluntary
meet
into
weekly
good
1022
making
intention
dependent
provision
west
protections
concern
sydney141102
suspend
260
state
tal
importing
asset_upload_file813_3398
violation
registered
prompted
numerous
deliberate
ular
merck
oliviera
secured
mirza
increasing
wto's
least
less
iminatib
berne
tenttype
analysis
decided
thewto_e
taxation
mis
declaration
paper
received
prescribing
update
oseltamivir
next
almost
embroiled
finding
overview
kazmin
biomedcentral
availa
liberalisation
cast
customs
cheaper
intended
restricting
company
anti
make
industry
maintaining
robust
themselves
august
tensions
agenda
leaving
glivec
world's
property
middle
clauses
fundamentally
rat
exclu
discourage
textiles
launched
viral
some
committee
adams
notably
281627
flex
tuberculosis
unrestricted
immunodeficiency
financial
sustainability
wake
respect
non
against
justifications
nr4234
playing
narrowing
obstacles
performers
mesylate
benefits
needs
focus
feasibility
basis
begin
ability
improve
longwood
profit
globalisation
pharmacoeconomics
resources
102
responded
authorises
glo
undoubtedly
positive
06_31
necessarily
levels
rapidly
scal
recom
behalf
com
recouping
hopes
vkerry
singapore
intense
henry
affirmation
creative
domestically
ified
bra
saving
hnp
import
hundred
registering
product
patents
ties
consider
alliance
lands
economies
break
lower
gleevac
612
specific
pursued
design
214
ter
interests
american
deputy
innovation
downloads
switzerland
snational
united
other
lukuge
macroeconomics
licenses
term
chemicals
university
lency
principle
correa
a21eda1006002653
initiative
dfidhealthrc
markets
inventions
view
committed
request
boycott
policies
cally
powerful
manner
crisis
aventis
7ht
wanted
neighbouring
lopez
economy
relatedly
write
rovira
commercial
guide
obscures
washington
favour
poorest
pressured
reports
choice
increasingly
office
well
news
potential
australia
concentrated
untested
carib
sources
reassessment
followed
towards
linked
implementing
470
wider
undermining_access_ftas
world
1744
emergency
greatest
early
licens
tection
ers
trade
cidcmh
amended
118
form
para
nal
virenz
give
hrw
exclusivity
figure
scare
being
terrorist
december
def
4th
costs
various
ongoing
c2bab81820a8
attempts
cant
man
tice
pubmed
porto
copyright
july
http
maintains
1999
leads
issues_papers
pdf
cerns
may
phrma
archived
different
functional
ciprfullfi
terms
bridges
mid
com_content
communities
thirds
examination
constraints
income
lamivudine
hard
int
number
healthgap
541
organization
now
return_on_revenues
pdfs
population
test
produce
resist
100
how
htb5
event
un
their
scale
best
drafted
nurse
therefore
sussex
impasse
ratification
interpretation
mckerrow
unsuccessfully
pressure
ifpma
carried
far
required
disputes
also
polic
evb
distribution
watershed
related
cancer
but
what_new
advocated
over
federal
erosion
agreement
pub
kerry1
prevent
improving
rethink
harvard
mitted
citation
receive
administrative
skewed
exhaustion
fund
fear
especially
include
unlikely
standing
cut
vested
papers
flexibil
evidence
ranbaxy
aidstechnet
256
stronger
compulsory
tenofovir
allows
worldwide
500
scrambled
sir
based
ures
peo
actions
giants
safer
priority
made
petitive
page
representatives
designation
pri
field
oping
posed
greater
such
degree
equivalent
unaffected
current
example
discussed
ftaa1029
atm
successfully
combining
member
programme
stockpiles
discrimination
economic
xxi
ward
time
specifying
round
murray
ment
combi
publications
cerned
springer
strengthen
governed
tections
routinely
human
framework
producers
procurement
complex
nine
apparent
breaks
notting
international
largest
represent
has
reaction
partners
2007
103
dozens
apart
achieve
production
worded
plus_through_eftas_back_door_rev2
cuba
useful
nether
coordinated
reliant
meas
continue
ingredi
buster
grant
cms
consequence
143
use
mednet2
ensuring
alongside
pugatch
week
despite
until
goals
citizen
files
overseas
1595
arise
pricing
therapy
pan
views
forces
brazilian
con
conference
charge
rep
taiwan
1590
essential
march
priorities
affirmations
authori
yielded
appropriately
subsequently
turing
establish
bioethics
negotia
proce
420
stages
macroeco
unwaver
growth
established
mean
began
tumours
sourcesprices
responsibility
20india
regulatory
scope
negotiations
brain
edu
issued
trips_stat_28aug03_e
frontiers
bet
primacy
range
cipro
medium
itemid
effect
specifi
fiftth
abbott
abstract
major
issues
greening
place
acknowledgements
bermudez
above
competition
combined
undermine
repre
manufacturers
recommend
aid
email
million
serve
clar
unwarranted
materials
practical
matters
ceded
regional
reduce
access
panama
elaborate
placed
scntid
mutually
setting
goal
type
authority
nongovernmental
context
note
supported
bilateral
there
0fed
amend
keeping
patent
market
favours
thailand
pharma
south
provides
top
underinvestment
informally
centred
hailed
occur
info
del
precedence
conferment
arising
china
perez
dis
espe
116
136
realisation
inter
authors
government
4604
price
researc
bayer
african
iprs
should
compounds
selected
seek
predominantly
applying
ity
lmics
bar
products
fighting
greenaway
singapore_fta
interest
frequently
poor
pharmaceuticals
frameworks
phosphate
watch
clinical
treatments
properly
recipient
index
origi
proposed
off
horse
known
riers
affordability
additional
exporters
signifi
ham
director
biomedical
harvey
straightforward
objectives
office's
line
helpful
result
kl
registration
solution
360
text
stated
house
inventiveness
grace
gov
plus
bradford
ministerial
innovations
need
esti
government's
does
denial
dc
outside
per
process
spiral
working
documents
manufactured
reform
business
power
filing
although
period
important
all
indian
campaigning
2006
argentina
systems
notable
8603
deliberation
development
removes
submit
control
including
provisions
fortune500
unless
sciences
created
vided
february
mit
itself
content
agriculture
pled
applications
lexchin
druce
agree
boston
essen
html
create
during
ministry
multiple
dfid_synthesis_aw
cases
accessing
chosen
tipo
equally
methods
recently
revised
enshrine
rio
pubs
complaints
sto
writing
decreasing
nongovernmen
317
rising
anticom
distributed
distinction
1186
attribution
open
cambo
significant
extended
medicins
tioned
curtailment
contained
precluded
iprcommission
beaglehole
assets
pressed
who's
designed
post
easily
shared
legislation
comes
pooled
respec
they
adopt
factories
popula
uct
russia
sales
bce1c69e
removal
trademarks
821
producer
weak
according
5dcb
251020051332373
cycle
options
20report
joint
leukaemia
210
suggest
release
novelty
promotion
defining
manufacturer
amounts
ini
upward
supports
basic
distinguish
substantially
acces
multi
implica
date
concerned
wrath
edited
life
extend
subject
stat
marketing
permanent
roche
system
month
uncertain
unsustaina
every
vanessa
declarations
national
20int
cptech
ma
policy
stand
avenue
434a
dem
diversification
purchasing
formally
brand
care
negotiating
pressing
heat
commitments
permits
highly
benefit
study
pharm
affect
fundamental
standards
case
vac
cines
killers
advocates
crossroad
debates
effectively
scherer
facing
pharmaceutical
about
roles
be9c
hinder
prove
399
sivity
sti571
rationale
formed
normal
technical
200
earned
own
innovatio
ket
east
security
obtaining
efa
cheap
english
struggles
representing
tially
exe
88694e5b
conceptualised
desh
marketed
includes
understood
linares
competing
active
resolved
donors
impact
achieved
run
manufacturing
mexico
negotiate
3813
urgency
precedent
lucrative
9602
cafta
hansen
maceutical
prohibiting
suppliers
currently
med
waiver
wto
aside
collection
frame
face
remains
to
dataexclusivitymay04
ease
provided
prescription
large
relatively
ation
attempt
built
treatment
patenting
nation
thai
damage
transitional
recognise
subsidies
long
commons
rec
appealed
accompa
determine
0000779e2340
initial
become
glaxosmithkline
congress
threats
took
central
consideration
tion
releases
several
commission
generation
lead
caution
ple
corporate
sixty
mayne
proactive
bangla
stable
entitlements
treat
corresponding
bullying
council
vulnerability
ngos
discussion
channels
protests
guarantee
2005
america
collaboration
anthrax
ulatory
encourage
ities
msc
vicious
second
docs_e
scheme
versus
advocacy
october
nottingham
wc1e
work
biotic
mined
latin
sell
ways
whether
pro
three
april
2011
cite
tballiance
was
nied
two
htb
estinian
each
africa
role
promise
assess
consternation
econom
backed
dia
attention
1095698140167
progress
bck
equiva
reaffirming
press_releases
economics
tropical
homedes
countries
trade_agreements
suggests
full
janeiro
fees
strengthened
faunce
efta
available
tiated
approved
block
however
accompanied
negoti
demic
grow
pric
one's
session
patients
confidential
vbk
ations
one
declara
minimum
brief
find
estimated
decision
allowed
site
expires
year
usa
ufacturer
prised
intellec
among
considered
influenza
threatening
bush
compa
balization
uments
approval
356
ical
concessions
pulsory
lessening
proportion
january
competitive
private
abbreviations
title
poverty
rule
still
incentives
will
medicines
reluctance
practices
dialogue
network
multilateral
watal
future
very
associations
ucts
status
requiring
problem
conquer
avoid
produced
signed
honduras
became
efta's
sitere
nelfinavir
107
mindecl_trips_e
tical
indeed
locally
demand
journal
unauthorised
then
mends
fifteen
drahos
removing
signing
quantity
billion
sans
involving
zoellick
oxfam
avert
argued
pending
sta
cur
151
chair's
increased
tba_economics_report
interna
six
moreover
extreme
globalising
often
cambridge
creativecommons
vision
arose
assert
thus
decline
similar
underdevelopment
1995
push
changes
nations
areas
indicate
same
seeks
named
free
bipartisan
criticism
situations
ipr
license
requisite
allow
taiwanese
others
rwandan
campaign
stringent
expiration
landlocked
president
aidsmap
politics
transition
kelley
815
here
lancet
caribbean
hong
shortage
aspects
vaguely
enforce
weaknesses
ver
omies
rescind
spread
hhs
expressed
anon
given
ensure
yet
simplification
authorization
bangkok
separate
sible
principal
2centre
article
offset
partic
imports
between
restrictive
peer
agreements
parallel
put
saquinavir
won
cerning
expert
minist_e
04_12
attack
500's
ldcs
enable
cnn
lectual
dose
fuel
offer
authoriza
2010
globalburdenofdis
organisations
mrazek
140
www
public
ingredient
prioritise
fully
tralia
diseases
taking
problems
other_documents
innova
lowered
socioeconomic
magazines
must
england
body
scientist
infringement
able
geneva
path
companies
using
stakeholder
min01_e
since
transnational
critical
gap
businessweek
1996
braithwaite
ing
ever
sale
carlos
section_index
fourth
tram
consumer
retroviral
immedi
appeared
encouraging
inability
clearly
lost
profitable
watched
ommendations
rwanda
written
limited
unable
manuscript
exerted
integral
within
globalizationandhealth
led
remedy
points
imatinib
rwanda's
concluded
organised
exclusive
nomics
traded
declare
enhanced
404
rently
2004
track
domestic
1st
trips
because
rights
backdoor
parison
cmhreport
dollars
waxman
realise
commis
legal
ics
jor
bank
level
opment
covered
says
pres03_e
industrialised
ble
adaptations
uk
done
castillo
mar
triple
federation
api
deals
gilead
grabowski
industries
broad
unevenly
delivery
longer
royalties
ceutical
them
uphold
used
supplying
delays
steps
true
mated
arv
hits
considerable
nor
press
when
responsible
background
bristol
ground
prop
openness
correspondingly
employs
appropri
reached
ple's
challenge
mirrors
tech
balasubramaniam
stark
efforts
20criteria
quickly
broader
993
timeline
worldbank
researchpapers
ducer
served
debate
secure
shall
further
base
change
econ
november
nec
developing
partnerships
bolar
thirty
responsibilities
afforded
influence
called
oped
initially
reg
mueller
ministers
resolve
regulation
step
neglect
comprehensive
administration
negotiated
gleevec
unknown
capacity
point
chal
pur
compliance
000
small
therapeutic
bulletin
20china
divide
duced
found
briefly
instead
expiry
3801
low
asks
extension
fifty
across
through
while
reviewing
buse
await
paul
funds
clear
offi
ques
developed
seeking
purposes
occasions
claimed
transfer
formal
licensing
school
patented
simplified
finally
circumstances
amendment
tions
read
stake
capabilities
once
surrounding
alleviate
tecting
strategy
purpose
tamiflu
expired
inherent
present
flexibili
see
statement
amid
ate
usc
oecs
intellectual
tingham
interim
version
either
health
02115
paragraph
review
applicability
chase
americas
commitment
lshtm
general
restrict
agreed
ukraine
authorised
efavirenz
five
organisation's
task
cp
dilute
discovering
concerns
stricter
list
out
reports_publications
legal_e
sectors
iddt
estimates
05ff
categories
publish
street
speeding
expense
organisation
acting
raise
social
chairperson's
generic
safety
short
requires
controversy
genuine
paid
chance
announcement
wt_l_540_e
2016
kerry
millions
fda
sacu
name
instance
loses
prices
extending
proviso
existing
refers
require
myers
requirement
stalled
asp
starting
stockpile
223
falvey
tailment
us
ents
granted
brought
immune
ately
around
reproduction
avoided
syndrome
cannot
along
not
undermining
years
drager
india's
principles
remain
division
invention
hiv
selection
severe
services
ugalde
reduced
prod
demands
remained
times
lee
standard
community
prejudice
dle
before
hindered
success
imbalances
inition
inception
high
availability
demonstrated
first
provisos
structure
2003